이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

심장 질환 병기에 따른 맞춤형 치료와 사건 예방을 위한 일반적인 치료의 무작위 비교 (TRANSFORM)

2026년 11월 18일 업데이트: Cleerly, Inc.

관상동맥 질환 병기 결정에 따른 맞춤형 치료와 심혈관 사건의 일차 예방을 위한 일반 치료의 무작위 비교

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease (CAD) Staging System-based care strategy reduces CV events compared with risk factor-based care.

연구 개요

상태

모병

정황

개입 / 치료

상세 설명

Cardiovascular disease (CVD) persists as the leading cause of morbidity and mortality worldwide at high societal cost. The current primary CVD prevention strategy relies upon risk stratification using population health markers such as age, sex, diabetes, hypertension, dyslipidemia and tobacco use, with preventive therapy intensified in higher risk strata. Since these risk factors are indirect surrogate markers of the underlying disease, atherosclerosis, this strategy leads to treatment of individuals with risk factors who do not have atherosclerosis and failure to treat those with significant atherosclerosis who lack risk factors. The current strategy also cannot determine which individuals are inadequately treated despite effective risk factor management (residual risk). With the current approach, the CV death rate is trending upward in the US despite evidence that screening asymptomatic patients reduces CV events and the widespread availability of effective preventive therapies.

This randomized, controlled, pragmatic trial is designed to address the unmet need for better strategies to identify asymptomatic individuals at increased risk for CV events due to atherosclerosis and to personalize their treatment based on CV risk estimates using coronary artery disease (CAD) visualization and quantification.

This study enrolls patients without known symptoms of ASCVD but who are at increased risk for ASCVD due to their age and having diabetes, prediabetes or metabolic syndrome and tests the hypothesis that a CAD Staging System-based care strategy reduces CV events compared with risk factor-based care. The Cleerly CAD Staging System incorporates imaging-based evaluation for coronary atherosclerosis, algorithm-supported pharmacotherapy and personalized education about their CAD.

연구 유형

중재적

등록 (추정된)

7500

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

    • Arizona
      • Chandler, Arizona, 미국, 85224
        • 모병
        • Chandler Clinical Trials
        • 연락하다:
          • Muhammad Salim, MD
      • Scottsdale, Arizona, 미국, 85260
        • 모병
        • Scottsdale Clinical Trials
        • 연락하다:
          • Todd Dreitzler, MD
      • Sun City, Arizona, 미국, 85381
        • 모병
        • Sun City Research
        • 연락하다:
          • Juan Rodriguez, MD
      • Tucson, Arizona, 미국, 85704
        • 모병
        • Noble Clinical Research
        • 연락하다:
          • Roxana Rodriguez, MD
    • California
      • Beverly Hills, California, 미국, 90210
        • 모병
        • Cardiovascular Research Foundation of Southern California
        • 연락하다:
          • Ronald P. Karlsberg, MD
      • Beverly Hills, California, 미국, 90211
        • 모병
        • Amicis Research: Beverly Hills
        • 연락하다:
          • Michael Levine, MD
      • Canoga Park, California, 미국, 91303
        • 모병
        • Valiance Clinical Research - Canoga Park
        • 연락하다:
          • Rami Shaarawy
      • Chula Vista, California, 미국, 91911
        • 모병
        • Cardiovascular Institute of San Diego
        • 연락하다:
          • Milind D. Parikh, MD
      • Granada Hills, California, 미국, 91324
        • 모병
        • Amicis Research: Granada Hills
        • 연락하다:
          • Pascal Dabel, MD
      • Huntington Park, California, 미국, 90255
        • 모병
        • Valiance Clinical Research: Huntington Park
        • 연락하다:
          • Philip Kim, MD
      • Indian Wells, California, 미국, 92210
        • 모병
        • HALO Diagnostics
        • 연락하다:
          • John F. Feller, MD
      • La Jolla, California, 미국, 92037
        • 모병
        • Scripps Health
        • 연락하다:
          • Elizabeth Epstein, MD
      • Lancaster, California, 미국, 93534
        • 모병
        • Chemidox Clinical Trials
        • 연락하다:
          • Pamela Dewar-DeSilva, MD
      • Loma Linda, California, 미국, 92354
        • 모병
        • Loma Linda University Health
        • 연락하다:
          • Purvi Parwani, MD
      • Long Beach, California, 미국, 90805
        • 모병
        • Long Beach Research Institute
        • 연락하다:
          • Ashley Duzik, MD
      • Monterey Park, California, 미국, 91754
        • 모병
        • Ace Research Institute - Monterey Park
        • 연락하다:
          • Yu-Hsiang Sam Lee, MD
      • Newhall, California, 미국, 91321
        • 모병
        • Amicis Research: Newhall
        • 연락하다:
          • Thuong Vo, MD
      • Northridge, California, 미국, 91324
        • 모병
        • Ace Research Institute: Northridge
        • 연락하다:
          • Richard Park, MD
      • Northridge, California, 미국, 91324
        • 모병
        • Amicis Research: Northridge
        • 연락하다:
          • Nana Barseghian, MD
      • Northridge, California, 미국, 91325
        • 모병
        • Ace Research Institute: Northridge #2
        • 연락하다:
          • William Y. Josephson, MD
      • Northridge, California, 미국, 91325
        • 모집하지 않고 적극적으로
        • Northridge Clinical Trials
      • Orange, California, 미국, 92868
        • 모병
        • University of California- Irvine
        • 연락하다:
          • Ailin Barseghian El-Farra, MD
      • Palo Alto, California, 미국, 94304
        • 모병
        • Stanford Health Care
        • 연락하다:
          • Sandra Tsai, MD
      • Palo Alto, California, 미국, 94304
        • 모병
        • VA Palo Alto
        • 연락하다:
          • Shriram Nallamshetty, MD
      • San Fernando, California, 미국, 91306
        • 모병
        • Amicis Research: San Fernando
        • 연락하다:
          • Farid Yasharpour, MD
      • Tarzana, California, 미국, 91356
        • 모병
        • Valiance Clinical Research - Tarzana
        • 연락하다:
          • Harpreet Singh, MD
      • Torrance, California, 미국, 90502
        • 모병
        • Lundquist Institute for Biomedical Innovation at Harbor - UCLA Medical Center
        • 연락하다:
          • Suvasini Lakshmanan, MD
      • Valencia, California, 미국, 91355
        • 모병
        • Amicis Research: Valencia
        • 연락하다:
          • Dennis Lewis, MD
      • Valley Village, California, 미국, 91607
        • 모병
        • Concierge Clinical Trials
        • 연락하다:
          • Neal R. Cutler, MD
    • Colorado
      • Aurora, Colorado, 미국, 80045
        • 모병
        • University of Colorado
        • 연락하다:
          • Steve Simon
        • 수석 연구원:
          • Steve Simon, MD
      • Denver, Colorado, 미국, 80218
        • 모병
        • St. Josephs (Intermountain Healthcare)
        • 연락하다:
          • Christopher Angus, MD
    • Florida
      • Boca Raton, Florida, 미국, 33434
        • 모병
        • Flourish Medical Research
        • 연락하다:
          • Michael Hafran, MD
      • Cross City, Florida, 미국, 32628
        • 모병
        • Apex Research
        • 연락하다:
          • Tamir Salmani, MD
      • Hialeah, Florida, 미국, 33012
        • 모병
        • Evolution Research Center
        • 연락하다:
          • Riquel Gonzalez, MD
      • Jacksonville, Florida, 미국, 32209
        • 모병
        • UF Health Jacksonville
        • 연락하다:
          • Luis Ortega Paz, MD
      • Miami, Florida, 미국, 33137
        • 모병
        • BioPhase Research
        • 연락하다:
          • Julie Cadet-Plassman, MD
      • Miami, Florida, 미국, 33135
        • 모병
        • Fiel Wellness Clinical Research LLC
        • 연락하다:
          • Osvaldo Caroma, MD
      • Miami, Florida, 미국, 33155
        • 모병
        • United Clinical Research
        • 연락하다:
          • Teresa B. Alfonso, MD
        • 연락하다:
          • Alfonso
      • Miami, Florida, 미국, 33173
        • 모병
        • Atlantis Clinical Research, LLC
        • 연락하다:
          • Leyvi Alvarado Miranda, MD
      • Miami, Florida, 미국, 33183
        • 모병
        • Farma Medical Inc.
        • 연락하다:
          • Ingrid Fernandez-Milian, MD
      • Miami, Florida, 미국, 33173
        • 모병
        • Baptist Health Miami Cardiac and Vascular Institute
        • 연락하다:
          • Jonathan Fialkow, MD
      • Miami, Florida, 미국, 33186
        • 모병
        • New Access Research and Medical Center
        • 연락하다:
          • Sander Fernandez, MD
      • Miami Beach, Florida, 미국, 33140
        • 모병
        • Quantum Clinical Trials
        • 연락하다:
          • Christopher A. Fayeghi, MD
      • Pensacola, Florida, 미국, 32504
        • 모병
        • Ascension Sacred Heart
        • 연락하다:
          • Rohit Amin, MD
      • Pompano Beach, Florida, 미국, 33060
        • 모병
        • Clinical Research Center of Florida
        • 연락하다:
          • Howard S. Koch, MD
      • Tampa, Florida, 미국, 33620
        • 모병
        • University of South Florida
        • 연락하다:
          • Shone Almeida, MD
    • Georgia
      • Augusta, Georgia, 미국, 30907
        • 모병
        • Aiyan Diabetes Center
        • 연락하다:
          • Anthony D. Turner, MD
      • Dunwoody, Georgia, 미국, 30338
        • 모병
        • Emory University
        • 연락하다:
          • Ambar Kulshreshtha, MD
      • Fayetteville, Georgia, 미국, 30214
        • 모병
        • Privia Medical Group Georgia LLC -Fayetteville (Javara)
        • 연락하다:
          • Charlotte Grayson Mathis, MD
      • Lithia Springs, Georgia, 미국, 30122
        • 모병
        • Randomize Now- Atlanta West
        • 연락하다:
          • Millard Collier Jr., MD
      • Macon, Georgia, 미국, 31210
        • 모병
        • Randomize Now-Burton Medical
        • 연락하다:
          • Frederick Burton, MD
      • Norcross, Georgia, 미국, 30092
        • 모병
        • Evergreen Clinical Trials
        • 연락하다:
          • Dmitriy Pelishev, MD
      • Powder Springs, Georgia, 미국, 30127
        • 모병
        • Peachtree Clinical Solutions - Noir Research Collective
        • 연락하다:
          • Karan Raghavan, MD
      • Riverdale, Georgia, 미국, 30296
        • 모병
        • Randomize Now, LLC - Noir Research Collective
        • 연락하다:
          • Claire K. Willie, MD
      • Savannah, Georgia, 미국, 31406
        • 모병
        • Privia Medical Group Georgia, LLC (Javara Inc.)
        • 연락하다:
          • Thomas G. Moriarity, MD
      • Thomasville, Georgia, 미국, 31792
        • 모병
        • Privia Medical Group Georgia - Thomasville (Javara)
        • 연락하다:
          • William L. Cooper, MD
    • Idaho
      • Meridian, Idaho, 미국, 83642
        • 모병
        • Care Institute- High Desert
        • 연락하다:
          • David A. Hinchman, MD
    • Illinois
      • Chicago, Illinois, 미국, 60611
        • 모병
        • Northwestern University
        • 연락하다:
          • Paul C. Cremer, MD
      • Glenview, Illinois, 미국, 60026
        • 모병
        • Northshore University Health System
        • 연락하다:
          • Amit K. Pursnani, MD
    • Indiana
      • Indianapolis, Indiana, 미국, 46237
        • 모병
        • Franciscan Physician Network- Indiana Heart Physicians
        • 연락하다:
          • Ryan P Daly, MD
      • Indianapolis, Indiana, 미국, 46202
        • 모병
        • Indiana Medical Research Institute
        • 연락하다:
          • Arshad P. Malik
    • Iowa
      • West Des Moines, Iowa, 미국, 50266
        • 모병
        • MercyOne Iowa Heart Center
        • 연락하다:
          • Enrico L. Martin, MD
    • Kentucky
      • Edgewood, Kentucky, 미국, 41017
        • 모병
        • St Elizabeth Health Care - CRI
        • 연락하다:
          • Erica Pivato, MD
      • Louisville, Kentucky, 미국, 40202
        • 모병
        • UofL Health
        • 연락하다:
          • Shahab Ghafghazi, MD
    • Louisiana
      • New Orleans, Louisiana, 미국, 70127
        • 모병
        • Ascension DePaul Services Research Center
        • 연락하다:
          • Kristen Thomas, MD
    • Maryland
      • Bowie, Maryland, 미국, 20715
        • 모병
        • Flourish Bowie dba Flourish Research
        • 연락하다:
          • Sara Collins, MD
      • Columbia, Maryland, 미국, 21045
        • 모병
        • KUR Research at CMP
        • 연락하다:
          • William Saway, MD
    • Massachusetts
      • Boston, Massachusetts, 미국, 02115
        • 모병
        • Brigham and Women's Hospital
        • 연락하다:
          • Ron Blankstein, MD
      • Boston, Massachusetts, 미국, 02114
        • 모병
        • Massachusetts General Hospital
        • 연락하다:
          • Pradeep Natarajan, MD
    • Michigan
      • Detroit, Michigan, 미국, 48202
        • 모병
        • Henry Ford Hospital
        • 연락하다:
          • Cori E Russell, MD
      • Ypsilanti, Michigan, 미국, 48917
        • 모병
        • Trinity Health Michigan Heart
        • 연락하다:
          • Ahmad Mizyed, MD
    • Minnesota
      • Minneapolis, Minnesota, 미국, 55407
        • 모병
        • Minneapolis Heart Institute Foundation
        • 연락하다:
          • Michael D. Miedema, MD
    • Missouri
      • St Louis, Missouri, 미국, 63110
        • 모병
        • Washington University School of Medicine
        • 연락하다:
          • Farhan M. Katchi, MD
      • St Louis, Missouri, 미국, 63136
        • 모병
        • Saint Louis Heart and Vascular
        • 연락하다:
          • Gil Vardi, MD
    • Montana
      • Kalispell, Montana, 미국, 59901
        • 모병
        • Boeson Research Kalispell
        • 연락하다:
          • Justin Buls, MD
      • Missoula, Montana, 미국, 59804
        • 모병
        • Boeson Research Fort Missoula
        • 연락하다:
          • Audrey Remmers, MD
    • Nebraska
      • Lincoln, Nebraska, 미국, 68506
        • 모병
        • Bryan Heart
        • 연락하다:
          • Chad E. Travers, MD
    • Nevada
      • Las Vegas, Nevada, 미국, 89128
        • 모병
        • Vector Clinical Trials
        • 연락하다:
          • Bharat R. Mocherla, MD
      • Las Vegas, Nevada, 미국, 89102
        • 모병
        • Southwest Medical Associates- Optum Nevada
        • 연락하다:
          • Tatiana O. Tsvetkova, MD
    • New Jersey
      • Flemington, New Jersey, 미국, 08822
        • 모병
        • Advanced Heart and Vascular Institute of Hunterdon
        • 연락하다:
          • Andrey Espinoza, MD
      • Marlton, New Jersey, 미국, 08053
        • 모병
        • Virtua Health, Inc.
        • 연락하다:
          • Mark T. Finch, MD
      • New Brunswick, New Jersey, 미국, 08901
        • 모병
        • Rutgers State University
        • 연락하다:
          • Sabahat Bokhari, MD
      • Paramus, New Jersey, 미국, 07652
        • 모병
        • The Valley Hospital
        • 연락하다:
          • Himanshu Gupta, MD
      • Teaneck, New Jersey, 미국, 07666
        • 모병
        • Holy Name Medical Center
        • 연락하다:
          • Jaffar Raza, MD
    • New York
      • Brooklyn, New York, 미국, 11221
        • 모병
        • Clindove Research
        • 연락하다:
          • Nelly Cohen, MD
      • Brooklyn, New York, 미국, 11226
        • 모병
        • Swift Clinical Research
        • 연락하다:
          • Manoj Dalmia, MD
      • Jackson Heights, New York, 미국, 11372
        • 모병
        • Rasaj Research
        • 연락하다:
          • Ammara Mushtaq, MD
      • Lake Success, New York, 미국, 11042
        • 모병
        • Optum- Long Island NY
        • 연락하다:
          • Steven Goldberg, MD
      • Mount Kisco, New York, 미국, 10549
        • 모병
        • Northwell Health Northern Westchester Hospital
        • 연락하다:
          • Margaret Andersen, MD
      • New York, New York, 미국, 10019
        • 모병
        • Mount Sinai West
        • 연락하다:
          • Waqas A Malick, MD
      • New York, New York, 미국, 10029
        • 모병
        • Mount Sinai
        • 연락하다:
          • Solomon Bienstock, MD
    • North Carolina
      • Chapel Hill, North Carolina, 미국, 27599
        • 모병
        • University of North Carolina at Chapel Hill
        • 연락하다:
          • Matthew Cavender, MD
      • Durham, North Carolina, 미국, 27701
        • 모병
        • Duke University Hospital
        • 연락하다:
          • William Yancy, MD
      • Durham, North Carolina, 미국, 27705
        • 모병
        • Durham Veterans Affairs Medical Center (Durham VAMC)
        • 연락하다:
          • Hayden Bosworth, MD
      • Fayetteville, North Carolina, 미국, 28304
        • 모병
        • Cape Fear Valley Health System (Javara Inc.)
        • 연락하다:
          • Nafisa Saleem, MD
      • Morehead City, North Carolina, 미국, 28557
        • 모집하지 않고 적극적으로
        • West Clinical Research
      • Winston-Salem, North Carolina, 미국, 27157
        • 모병
        • Wake Forest University Health Sciences
        • 연락하다:
          • Michael Shapiro, MD
    • North Dakota
      • Fargo, North Dakota, 미국, 58102
        • 모병
        • Sanford Health
        • 연락하다:
          • David J. Clardy, MD
    • Ohio
      • Akron, Ohio, 미국, 44304
        • 모병
        • Summa Health
        • 연락하다:
          • Wissam Alajaji, MD
    • Oklahoma
      • Oklahoma City, Oklahoma, 미국, 73109
        • 모병
        • Medical Research International, LLC
        • 연락하다:
          • Joseph Grillo, MD
      • Oklahoma City, Oklahoma, 미국, 73007
        • 모병
        • Hightower Clinical
        • 연락하다:
          • Faisal Latif, MD
      • Tulsa, Oklahoma, 미국, 74104
        • 모병
        • Ascension St. John - Jane Phillips Medical Center
        • 연락하다:
          • Michael Megaly, MD
    • Pennsylvania
      • Camp Hill, Pennsylvania, 미국, 17011
        • 모병
        • Capital Area Research
        • 연락하다:
          • Venkatesh Nadar, MD
    • South Carolina
      • Charleston, South Carolina, 미국, 29425
        • 모병
        • Medical University of South Carolina
        • 연락하다:
          • Marc-Andre Cornier, MD
    • Tennessee
      • Cleveland, Tennessee, 미국, 37312
        • 모병
        • Community DPC
        • 연락하다:
          • Carlton Volberg, MD
      • Knoxville, Tennessee, 미국, 37920
        • 모병
        • University of Tennessee Medical Center
        • 연락하다:
          • Kashif A. Shaikh, MD
      • Nashville, Tennessee, 미국, 37202
        • 모병
        • TriStar Centennial Medical Center (HCA Health Care)
        • 연락하다:
          • David Huneycutt, MD
    • Texas
      • Abilene, Texas, 미국, 79601
        • 모병
        • Hendrick Health
        • 연락하다:
          • Ren Zhang, MD
      • Beaumont, Texas, 미국, 77702
        • 모병
        • Gadolin Research
        • 연락하다:
          • John T Fowler, MD
      • Greenville, Texas, 미국, 75402
        • 모병
        • CardioVoyage, LLC
        • 연락하다:
          • Marc Demyun, MD
      • Houston, Texas, 미국, 77025
        • 모병
        • Kelsey Research Foundation
        • 연락하다:
          • Rohan R Wagle, MD
      • Houston, Texas, 미국, 77004
        • 모병
        • Helium Research Group
        • 연락하다:
          • Ijeoma A. Ekeruo
      • Houston, Texas, 미국, 77070
        • 모병
        • Gulf Coast Clinical Research, LLC
        • 연락하다:
          • Anjani Pandya, MD
      • Houston, Texas, 미국, 77030
        • 모병
        • The Methodist Hospital, DeBakey Cardiology Associates
        • 연락하다:
          • Sadeer Al-Kindi, MD
      • Laredo, Texas, 미국, 78041
        • 모병
        • Aeres Clinical Research
        • 연락하다:
          • Amando Garza, MD
      • Lewisville, Texas, 미국, 75057
        • 모병
        • DC Clinical Research
        • 연락하다:
          • Moiz M. Shafiq, MD
      • McKinney, Texas, 미국, 75069
        • 모병
        • North Dallas Research Associates - Kerlo Network
        • 연락하다:
          • Muhammad Akram Khan, MD
      • Mesquite, Texas, 미국, 75149
        • 모병
        • SMS Clinical Research
        • 연락하다:
          • Salma Saiger, MD
      • San Marcos, Texas, 미국, 78666
        • 모병
        • Privia Medical Group Gulf Coast, PLLC ( Javara Inc.)
        • 연락하다:
          • Alan Lee, MD
      • Stephenville, Texas, 미국, 76401
        • 모병
        • Privia Medical Group- North Texas
        • 연락하다:
          • Benjamin Marcum, MD
    • Utah
      • West Valley City, Utah, 미국, 84120
        • 아직 모집하지 않음
        • Kalo Clinical Research
        • 연락하다:
          • William J. Walsh, MD
    • Virginia
      • Richmond, Virginia, 미국, 23225
        • 모병
        • Chippenham Johnston Willis Medical Center
        • 연락하다:
          • Michael Arcarese, MD
    • Washington
      • Everett, Washington, 미국, 98201
        • 모병
        • Providence Regional Medical Center Everett
        • 연락하다:
          • Xiaojing Jennie Shen, MD
      • Seattle, Washington, 미국, 98195
        • 모병
        • University of Washington
        • 연락하다:
          • Kelley Branch, MD
    • West Virginia
      • Charleston, West Virginia, 미국, 25304
        • 모병
        • Charleston Area Medical Center
        • 연락하다:
          • Sarah Rinehart, MD

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

55년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

예

연구 대상 성별

모두

설명

Inclusion Criteria:

  1. Provided electronic or written informed consent

  2. Men > 55, women > 65 years of age

  3. Type 2 diabetes mellitus requiring pharmacologic therapy or with their most recent A1c 6.5%. Patients with prediabetes (most recent HbA1c 5.7 to 6.4% and/or fasting glucose 100-125 mg/dL [5.6-6.9 mmol/L]) and/or metabolic syndrome can be enrolled through 12 October 2026 and proceed with randomization; however, no additional participants may enroll with these criteria after this date. Metabolic syndrome is defined as > 3 of the following criteria (International Diabetes Federation 2006):

    • Body mass index ≥ 27 kg/m2 or abnormal waist circumference defined as ≥ 80 cm (31.5 inches) for women, ≥ 94 cm (37 inches) for men; for South and East Asian men (e.g., Asian Indian, Chinese, Japanese) ≥ 90 cm (35.4 inches)
    • Fasting triglycerides ≥ 150 mg/dL (1.7 mmol/L) or treated hypertriglyceridemia
    • HDL-cholesterol (HDL-C) < 40 mg/dL (1.03 mmol/L) in men, <50 mg/dL (1.29 mmol/L) in women or treatment for this lipid abnormality
    • Systolic blood pressure (BP) ≥ 130 and/or diastolic BP≥ 85 mm Hg and/or treated hypertension
    • Fasting blood glucose ≥ 100 mg/dL (5.6 mmol/L) or HbA1c ≥ 5.7%
  4. Have a device (e.g., smartphone, tablet, computer) for communication with the central cardiologist-led team managing drug treatment for the personalized care group

Exclusion Criteria:

  1. Any one of the following:

    1. A history of acute myocardial infarction (heart attack), stroke, or non-traumatic leg/foot/toe amputation
    2. A history of an arterial revascularization procedure for coronary, peripheral, and/or carotid atherosclerotic disease (i.e. coronary stent or bypass, carotid stent)
    3. Symptoms suspicious of coronary artery disease, stroke or peripheral artery disease confirmed by a diagnostic test within the last 12 months (i.e. nuclear stress test, invasive angiogram, brain MRI/CT
    4. Asymptomatic ASCVD including treatment with therapies (e.g. antiplatelets, lipid lowering) intended to reduce CV risk due to the imaging evidence of atherosclerosis and/or management to goals consistent with secondary prevention guidelines (e.g. LDL-C < 70 mg/dL)
  2. Planned arterial revascularization

  3. Inability to complete screening CCTA or any condition that would increase the risk associated with CCTA or increase likelihood of uninterpretable scan including:

    1. eGFR < 60 mL/min/1.73 m2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD EPI) or Modification of Diet in Renal Disease (MDRD) equation (www.kidney.org/professionals/kdoqi/gfr_calculator)
    2. Allergy to iodinated contrast or history of contrast-induced nephropathy (including adverse reaction to contrast at screening CCTA) or screening laboratory values consistent with untreated hyperthyroidism. Participants with elevated thyroid-stimulating hormone (TSH) may be enrolled but should be referred to their physician for evaluation for treatment.
    3. Thyroid cancer in the previous five (5) years or planned radioactive iodine treatment
    4. Weight > 300 lbs. (136 kg) or above manufacturer-recommended limit for scanner and table at the site
    5. Inability to hold breath for > 10 seconds
    6. Active arrhythmia (atrial fibrillation, atrial flutter, frequent premature atrial, or ventricular contractions) with poorly controlled rate (i.e., > 80 beats per minute at screening or prior to CCTA)
    7. Contraindication to dosing with beta blocker or nitroglycerin on day of screening CCTA
    8. Any other factor that, in the opinion of the investigator, would increase participant risk or increase the chance of an uninterpretable CCTA
  4. Unsuitable as a trial participant in the opinion of the investigator for reasons including significant left main stenosis (e.g. ≥ 70%; site will be notified by Cleerly), other health condition with life expectancy < 3 years or being at risk of poor compliance with study procedures (e.g., active substance abuse or untreated mental illness that, in the opinion of the investigator, is likely to adversely affect adherence or retention)

  5. Unwilling or unable to receive specialty care per the trial protocol

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 방지
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: Risk Factor-Based Care

The risk factor-based care group will be managed by their usual care providers, with an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. During the trial, the centralized cardiology team will monitor the provision of medications prescribed and lab values relative to guidelines, and provide feedback and education to site investigators to support optimization. CCTA results will be centrally archived and will remain blinded to the usual care provider until the end of the study.

실험적: Cleerly Stage-Based Care

The Cleerly Stage-Based Care group will receive personalized care centrally managed by a remote cardiologist-led team. They will also receive an initial pre-randomization assessment of current treatment by a centralized cardiology team to optimize care relative to primary prevention guidelines. Cleerly CAD Staging System results will be discussed with participants and serve as the basis for standardized algorithm-supported pharmacotherapy & education, which will be intensified if plaque burden has progressed at 24 months.

The Cleerly CAD Staging System is software that utilizes a proprietary algorithm to identify CAD, stage the severity of CAD when present, and generate a prognostic risk score to inform treatment decisions that support CV disease prevention.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
The primary objective is to compare Cleerly stage-based care with risk factor-based care on the risk of CV events.
기간: Through study completion- an average of 3.5 years

The primary endpoint is total (first and subsequent) events for the composite endpoint of CV death, myocardial infarction (MI), ischemic stroke, acute limb ischemia, clinically driven arterial revascularization, and hospitalization or urgent visit for heart failure.

Through study completion- an average of 3.5 years

2차 결과 측정

결과 측정
측정값 설명
기간
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
기간: Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to first occurence of an event in the primary efficacy endpoint.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
기간: Through study completion- an average of 3.5 years

The secondary endpoints are total occurences after randomization of the primary efficacy endpoing, kidney failure, sustained estimated glomerular filtration rate (eGFR) decrease >40% from baseline, and death from renal causes.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
기간: Through study completion- an average of 3.5 years

The secondary endpoints are first and total occurrences after randomization of coronary death, MI, and urgent coronary revascularization.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
기간: Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to first occurrence of MI or ischemic stroke.

Through study completion- an average of 3.5 years
The secondary objective is to compare Cleerly CAD stage-based care with risk factor-based care on other clinical events of CV and renal morbidity and mortality.
기간: Through study completion- an average of 3.5 years

The secondary endpoints are time from randomization to all-cause death.

Through study completion- an average of 3.5 years

기타 결과 측정

결과 측정
측정값 설명
기간
The safety objective is to assess harm with the 2 prevention strategies
기간: Through study completion- an average of 3.5 years

The safety endpoints are Adverse events (AE) leading to discontinuation of study-recommended medication (DAE), serious AE (SAE), adverse device effect (ADE).

Through study completion- an average of 3.5 years
The safety objective is to assess harm with the 2 prevention strategies
기간: Through study completion- an average of 3.5 years

The safety endpoints are 20-item Short Form survey (SF-20).

Through study completion- an average of 3.5 years

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

협력자

수사관

  • 연구 의자: Deepak Bhatt, MD, MPH, Mt. Sinai Heart
  • 연구 의자: David J. Maron, MD, FASPC, Stanford University

간행물 및 유용한 링크

연구에 대한 정보 입력을 담당하는 사람이 자발적으로 이러한 간행물을 제공합니다. 이것은 연구와 관련된 모든 것에 관한 것일 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 3월 6일

기본 완료 (추정된)

2029년 3월 5일

연구 완료 (추정된)

2029년 3월 5일

연구 등록 날짜

최초 제출

2023년 10월 2일

QC 기준을 충족하는 최초 제출

2023년 10월 31일

처음 게시됨 (실제)

2023년 11월 1일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 19일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 18일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • 202302CPC

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

예

미국에서 제조되어 미국에서 수출되는 제품

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .